Telephone
61.3.8622.5780
Address
Level 6 720 Bourke Street Docklands, Victoria (VIC) 3008
Description
Medibank Private Ltd. engages in the underwriting and distribution of private health insurance policies. It operates through Health Insurance and Medibank Health segments. The Health Insurance segment offers private health insurance products including hospital cover and ancillary cover, as stand-alone products and packaged products. The Medibank Health segment refers to a range of activities including contracting with government and corporate customers to provide health management services, as well as providing a range of telehealth services in Australia. The company was founded in 1976 and is headquartered in Docklands, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 3.33 - 3.94
Trade Value (12mth)
AU$5,739,165.00
1 week
1.59%
1 month
2.68%
YTD
7.28%
1 year
10.37%
All time high
3.94
EPS 3 yr Growth
62.200%
EBITDA Margin
0.00%
Operating Cashflow
$258m
Free Cash Flow Return
12.60%
ROIC
24.90%
Interest Coverage
0.00
Quick Ratio
0.00
Shares on Issue (Fully Dilluted)
2754m
HALO Sector
Other Finance
Next Company Report Date
22-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.98
Date | Announcements |
---|---|
04 July 24 |
Notification of cessation of securities - MPL
×
Notification of cessation of securities - MPL |
02 July 24 |
Notification regarding unquoted securities - MPL
×
Notification regarding unquoted securities - MPL |
05 June 24 |
Medibank cybercrime event - AIC files proceedings
×
Medibank cybercrime event - AIC files proceedings |
20 May 24 |
Give back commitment increased to $305 million for customers
×
Give back commitment increased to $305 million for customers |
17 May 24 |
FY24 Full Year - Key Dates
×
FY24 Full Year - Key Dates |
17 May 24 |
Updated Share Trading Policy
×
Updated Share Trading Policy |
07 May 24 |
Medibank shares business update and healthcare insights
×
Medibank shares business update and healthcare insights |
04 April 24 |
Notification of cessation of securities - MPL
×
Notification of cessation of securities - MPL |
22 March 24 |
Initial Director's Interest - Jay Weatherill
×
Initial Director's Interest - Jay Weatherill |
05 March 24 |
Medibank announces approved premium increase
×
Medibank announces approved premium increase |
29 February 24 |
Change of Director's Interest - Linda Nicholls
×
Change of Director's Interest - Linda Nicholls |
22 February 24 |
Medibank to return $215m to customers
×
Medibank to return $215m to customers |
22 February 24 |
HY24 Results - Appendix 4D and Financial Report
×
HY24 Results - Appendix 4D and Financial Report |
22 February 24 |
Dividend/Distribution - MPL
×
Dividend/Distribution - MPL |
22 February 24 |
HY24 Results - Media Release
×
HY24 Results - Media Release |
22 February 24 |
HY24 Results - Investor Presentation
×
HY24 Results - Investor Presentation |
22 February 24 |
Medibank appoints non-executive director
×
Medibank appoints non-executive director |
22 January 24 |
AASB 17 Transition Update
×
AASB 17 Transition Update |
11 January 24 |
Updated Share Trading Policy
×
Updated Share Trading Policy |
11 January 24 |
Notification of cessation of securities - MPL
×
Notification of cessation of securities - MPL |
20 December 23 |
FY24 Half Year - Key Dates
×
FY24 Half Year - Key Dates |
18 December 23 |
Change of Director's Interest - David Koczkar
×
Change of Director's Interest - David Koczkar |
18 December 23 |
Notification regarding unquoted securities - MPL
×
Notification regarding unquoted securities - MPL |
07 December 23 |
Medibank increases primary care investment through Myhealth
×
Medibank increases primary care investment through Myhealth |
28 November 23 |
Final Director's Interest Notice - Anna Bligh
×
Final Director's Interest Notice - Anna Bligh |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.